October 2022 - Page 18 of 22

FridayOct 07, 2022 11:34 am

QualityStocksNewsBreaks – Tingo Inc. (TMNA), MICT Inc. (NASDAQ: MICT) Enter Merger Agreement for Acquisition

Tingo (OTC: TMNA), a leading agri-fintech business in Africa, and MICT Inc. (NASDAQ: MICT), have signed a merger agreement outlining plans for MICT to acquire 100% of the operating business and assets of Tingo. According to the announcement, the new merger with the accompanying MICT funding should expedite the launch of Tingo’s food-produce export business; existing high-margin and material export contracts will allow a substantial portion of Tingo’s revenues to shift directly into U.S. dollars. In an amendment, the two companies accelerated and restated the original agreement and merger plan. The transaction will also support the acceleration of the development and…

FridayOct 07, 2022 11:15 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Working to Address Declining Antihypertensive Intensification and High Prescription Abandonment Rates, with DehydraTECH-CBD

Lexaria is a global innovator in drug delivery platforms developing DehydraTECH-CBD as a potential treatment for hypertension A 2022 study documented a decline in the percentage of patients receiving appropriate treatment intensification over the last ten years This decline has been attributed to, among other possible reasons, the side effects of antihypertensive drugs At the same time, only 24% of adults with hypertension have the condition under control, a statistic attributable to the medications’ troublesome side effects Lexaria’s investigations of its DehydraTECH-CBD have so far presented favorable safety and tolerability data, meaning its drug candidate could offer reprieve to millions…

FridayOct 07, 2022 11:11 am

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Advancement of Berubicin Clinical Trial Featured in Syndicated Broadcast

CNS Pharmaceuticals (NASDAQ: CNSP), a clinical stage biotechnology company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced that it was featured in a broadcast via NetworkNewsAudio (“NNA”), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to thousands of syndication points. The audio release covers CNS Pharmaceuticals’ recent announcement that highlights the activation of its first clinical trial sites in Europe for the ongoing potentially pivotal global trial evaluating Berubicin for the treatment of glioblastoma multiforme (“GBM”), one of the…

FridayOct 07, 2022 10:30 am

GSMI Future Workforce Conference – Exploring Digital Support in Workplaces

The GSMI Future Workforce Conference is being held on October 11-13, 2022, as a virtual event. It is a great networking opportunity designed for decision-makers, HR executives, strategy and data analytics experts, and talent acquisition professionals from diverse industries to connect and collaborate on a common platform. At the Future Workforce Conference, traders can network and connect with top executives and company heads looking for robust strategies and ideas for investing in digital, remote, and hybrid work teams in their organizations. The Future Workforce team curates tailored sponsorship experiences by integrating new processes, technologies, and strategies for evolving workplace concepts.…

FridayOct 07, 2022 9:45 am

FuelPositive Corp. (TSX.V: NHHH) (OTCQB: NHHHF) Working to Eliminate Emissions Linked to Grey Ammonia Production, Manure Use

FuelPositive is a technology company developing an onsite, containerized, green ammonia production system that decarbonizes and decentralizes ammonia production With the world currently experiencing a fertilizer crisis, experts opine that the answer to the issue lies with the adoption of better agriculture practices rather than increased fertilizer production On its part, FuelPositive is working on a multi-pronged approach that eliminates not only the greenhouse emissions associated with the production of traditional (“grey”) but also the emissions linked to manure application The company is advocating for deep injection of green ammonia into the ground to prevent pollution of groundwater and waterbodies…

FridayOct 07, 2022 9:00 am

Companies and Property Owners Seeking Ways to Meet SEC Climate Risk Disclosure Requirements; Correlate Infrastructure Partners Inc. (CIPI) is Ready to Help

The growing environmental regulations are prompting companies to explore ways to meet ESG (Environmental, Social, and Governance) goals, but which can come at a hefty up-front cost, a significant disadvantage to small and medium enterprises Energy optimization solution provider Correlate, through its smart team of experts and evolving technologies, makes solutions extremely affordable to more companies, businesses, and real estate owners The company has positioned itself as a one-stop shop for those looking to explore renewable energy sources, reduce their carbon emissions, meet government regulations, and achieve their ESG goals, covering all aspects, including planning, financing, and execution Environmental, Social,…

ThursdayOct 06, 2022 2:31 pm

QualityStocksNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Elevating Performance with Expanded Team

Flora Growth Corp. (NASDAQ: FLGC), throughout 2022, has been implementing its hiring strategy that has seen the appointment of several key individuals whose proven talents and productivity are critical to the company’s goal of delivering the most compelling customer experiences. “Flora Growth ushered in the new year with the appointment of Tim Leslie as chairman of its newly formed advisory board. It would later bring Derek Pedro, an industry-leading cannabis genetics and cultivation expert, on board as an advisor and named Vessel founder James Choe as chief strategy officer. In February 2022, Flora Growth announced the appointment of Jessie Casner…

ThursdayOct 06, 2022 2:14 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Redefining Drug Delivery Platforms

Lexaria Bioscience Corp. (NASDAQ: LEXX) has remained committed to improving the way active pharmaceutical ingredients (“APIs”) enter the bloodstream. “Moreover, as a global innovator in drug delivery platforms, the company has not shied away from advancing its research to cut across various health conditions, including but not limited to hypertension, epilepsy, diabetes, and dementia, among others. These efforts have yielded 27 granted patents around the world since 2014, with approximately 50 additional patents pending. It also has national filings in over 40 jurisdictions with the highest commercial potential, reflecting the company’s commitment to creating shareholder value and pushing its technology…

ThursdayOct 06, 2022 1:59 pm

QualityStocksNewsBreaks – Sugarmade Inc. (SGMD) Lays Foundation for Significantly Expanded Manufacturing, Distribution Infrastructure

Sugarmade (OTC: SGMD), an emerging leader in the licensed cannabis sector, recently signed a management services agreement (“MSA”), marking a key milestone as the company actively strengthens its position in the California cannabis space. “SGMD signed the MSA through its subsidiary, SugarRush, which entered into the agreement with Canndis Inc., a California cannabis micro license holder. Canndis holds a license that covers delivery, manufacturing, distribution, and cultivation rights, and the agreement will enable Sugarmade to expand its manufacturing and distribution footprint,” a recent article reads. “Sugarmade is anticipating harvesting [its first crop], an accomplishment made possible through the company’s acquisition…

ThursdayOct 06, 2022 1:09 pm

QualityStocksNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) to Participate at Upcoming Dawson James Small Cap Growth Conference

Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, is scheduled to participate in the 7th annual Dawson James Small Cap Growth Conference. Silo Pharma CEO Eric Weisblum will present at the event, which is scheduled for Oct. 12, 2022, in Jupiter, Florida. Weisblum’s presentation will include an overview of Silo Pharma’s acquisition and development of intellectual property and technology rights from leading universities and researchers, including the use of the psychedelic drugs. The presentation will also feature a summary of Silo’s the diversified pipeline, which is focused on underserved rare disease,…

Site Search

Company Search

Month: October 2022